ConvaTec Group PLC

Company Snapshot

Founded: 1978
Entity Type: Public
Employees: 10,910
Region: North America
Revenue: $2,439.0 Millions
Revenue Year: 2025
Headquarter: London, U.K.
Key Geographics: North America, Europe
Corporate Address: 7th Floor, 20 Eastbourne Terrace Paddington, London W2 6LG U.K. www.convatecgroup.com

Company Overview

Convatec Group PLC is a manufacturer of medical products operating in four business segments: advanced wound care (AWC), ostomy care, continence and critical care, and infusion care. Its AWC segment encompasses advanced dressings, including foams, antimicrobials, composite/island dressings, alginate and fiber dressings, contact layers, hydrocolloids, films, super absorbents, and hydrogels, as well as external devices such as negative-pressure wound therapy, debridement, energy therapy, and oxygen therapy. It delivers products and services in around 90 countries across four continents. Its products provide numerous therapeutic and financial benefits, including infection prevention, protection for at-risk skin, improved patient outcomes, and reduced overall healthcare costs.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

ConvaTec Group PLC In Reports

Biologic Therapies for Wound Care: Technologies and Global Markets

According to BCC Research detailed report on Biologic Therapies for Wound Care Markets includes global revenue ($ billion) for the base year (2024), estimated data for 2025, and forecast data for 2026 to 2030.

Negative Pressure Wound Therapy (NPWT) Devices: Global Markets

According to BCC Research detailed report on Negative Pressure Wound Therapy (NPWT) Devices Markets includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through...

Disposable Ostomy Bags: Global Market

According to our Research Report the Disposable Ostomy Bags market segmentationsto determine thehistorical (2022), base year(2023) estimated year (2024), and future market status and forecast market growth from 2025 to...

Company's Business Segments

  • Advanced Wound Care ex‑InnovaMatrix : This segment includes Advanced Wound Care, Ostomy Care, Continence Care, Infusion Care.
  • InnovaMatrix revenue : This segment includes Hospital Care, Related Industrial Sales.

Applications/End User Industries

  • Antimicrobial
  • Advanced Tissue Technologies
  • Single-use Disposable Negative Pressure Wound Therapy
  • Pouch Solutions
  • Catheter Products
  • Precision Drug
  • Diabetes Management
  • Industrial Sales
  • Healthcare
  • Wound Care
AI Sentiment